Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Drug Discovery Today
|
June 14, 2008
Bayesian versus Frequentist statistical modeling: a debate for hit selection from HTS campaigns
L Martin Cloutier, Suzanne Sirois
Drug Discovery Today
|
August 5, 2008
Needed: system dynamics for the drug discovery process
Suzanne Sirois, L Martin Cloutier
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
October 5, 2006
A first QSAR model for galectin-3 glycomimetic inhibitors based on 3D docked structures
Suzanne Sirois, Denis Giguère, René Roy
Current Protein & Peptide Science
|
October 27, 2005
HIV-1 gp120 V3 loop for structure-based drug design
Suzanne Sirois, Tobias Sing, Kuo-Chen Chou
Current Medicinal Chemistry
|
January 29, 2008
Glycosylation of HIV-1 gp120 V3 loop: towards the rational design of a synthetic carbohydrate vaccine
Suzanne Sirois, Mohamed Touaibia, Kuo-Chen Chou, et al.
Journal of Chemical Information and Computer Sciences
|
May 25, 2004
Virtual screening for SARS-CoV protease based on KZ7088 pharmacophore points
Suzanne Sirois, Dong-Qing Wei, Qishi Du, et al.
Analytical Biochemistry
|
February 5, 2005
Molecular modeling and chemical modification for finding peptide inhibitor against severe acute respiratory syndrome coronavirus main proteinase
Qishi Du, Shuqing Wang, Dongqing Wei, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 13, 2006
Aryl O- and S-galactosides and lactosides as specific inhibitors of human galectins-1 and -3: role of electrostatic potential at O-3
Denis Giguère, Sachiko Sato, Christian St-Pierre, et al.
Computational Biology and Chemistry
|
February 1, 2005
Assessment of chemical libraries for their druggability
Suzanne Sirois, George Hatzakis, Dongqing Wei, et al.
Current Medicinal Chemistry
|
December 16, 2006
Progress in computational approach to drug development against SARS
Kuo-Chen Chou, Dong-Qing Wei, Qi-Shi Du, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Drug Discovery Today
|
June 14, 2008
Bayesian versus Frequentist statistical modeling: a debate for hit selection from HTS campaigns
L Martin Cloutier, Suzanne Sirois
Drug Discovery Today
|
August 5, 2008
Needed: system dynamics for the drug discovery process
Suzanne Sirois, L Martin Cloutier
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
October 5, 2006
A first QSAR model for galectin-3 glycomimetic inhibitors based on 3D docked structures
Suzanne Sirois, Denis Giguère, René Roy
Current Protein & Peptide Science
|
October 27, 2005
HIV-1 gp120 V3 loop for structure-based drug design
Suzanne Sirois, Tobias Sing, Kuo-Chen Chou
Current Medicinal Chemistry
|
January 29, 2008
Glycosylation of HIV-1 gp120 V3 loop: towards the rational design of a synthetic carbohydrate vaccine
Suzanne Sirois, Mohamed Touaibia, Kuo-Chen Chou, et al.
Journal of Chemical Information and Computer Sciences
|
May 25, 2004
Virtual screening for SARS-CoV protease based on KZ7088 pharmacophore points
Suzanne Sirois, Dong-Qing Wei, Qishi Du, et al.
Analytical Biochemistry
|
February 5, 2005
Molecular modeling and chemical modification for finding peptide inhibitor against severe acute respiratory syndrome coronavirus main proteinase
Qishi Du, Shuqing Wang, Dongqing Wei, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 13, 2006
Aryl O- and S-galactosides and lactosides as specific inhibitors of human galectins-1 and -3: role of electrostatic potential at O-3
Denis Giguère, Sachiko Sato, Christian St-Pierre, et al.
Computational Biology and Chemistry
|
February 1, 2005
Assessment of chemical libraries for their druggability
Suzanne Sirois, George Hatzakis, Dongqing Wei, et al.
Current Medicinal Chemistry
|
December 16, 2006
Progress in computational approach to drug development against SARS
Kuo-Chen Chou, Dong-Qing Wei, Qi-Shi Du, et al.
Page
of 2